Contingency Management to Promote Smoking Abstinence in Cancer Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

282 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-11-25

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a smoking cessation treatment study. Patients who have a cancer or a suspected cancer who will undergo surgical removal of their cancer are eligible to participate in this study. A novel smoking cessation treatment will be provided to half of the participants in the study. All study participants will receive standard smoking cessation therapy including counseling and the nicotine patch.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Novel Treatment to Enhance Smoking Cessation Before Cancer Surgery

NCT02402023

Smoking Cessation

COMPLETED NA

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

NCT00002520

Bladder Cancer Breast Cancer Colorectal Cancer +7 more

COMPLETED NA

Evidence-Based Tobacco Cessation Strategies in Patients With Cancer

NCT02211196

Malignant Neoplasm

COMPLETED NA

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

NCT01434342

Lung Cancer Tobacco Use Disorder Breast Cancer +2 more

COMPLETED EARLY_PHASE1

Novel Treatments to Enhance Smoking Cessation Before Cancer Surgery: Effects on Smoking and Surgical Outcomes

NCT01479998

Smoking Cessation

TERMINATED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Cessation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Contingency Management

Group Type EXPERIMENTAL

Contingency Management

Intervention Type COMBINATION_PRODUCT

Participants will receive 3-6 counseling sessions, nicotine patches \& lozenges, and monetary payment delivered contingent on abstinence verified by CO breath test.

Standard Care

Group Type ACTIVE_COMPARATOR

Standard Care

Intervention Type COMBINATION_PRODUCT

Participants will receive 3-6 counseling sessions, nicotine patches \& lozenges, and CO breath test monitoring.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Contingency Management

Participants will receive 3-6 counseling sessions, nicotine patches \& lozenges, and monetary payment delivered contingent on abstinence verified by CO breath test.

Intervention Type COMBINATION_PRODUCT

Standard Care

Participants will receive 3-6 counseling sessions, nicotine patches \& lozenges, and CO breath test monitoring.

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age 18 or older
2. smoking 1 or more combustible tobacco products per day
3. diagnosed with or suspicion of any type of operable cancer

Exclusion Criteria

1. unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis, or dementia
2. non-English speaking
3. use of alternative nicotine delivery systems (e.g., e-cigarettes, snus, etc)
4. pregnant women

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No